There are 2789 resources available
48P - (BREGO) Regorafenib combined with modified m-GEMOX in patients with advanced biliary tract cancer (BTC): A phase II randomized trial
Presenter: Eric Assenat
Session: ePoster Display
54P - Assessment of EU4 laboratory readiness for FGFR2 fusion testing of cholangiocarcinoma by NGS
Presenter: Marianna Sciortino
Session: ePoster Display
55P - Integrative genomic analysis identified primary cilium-associated genes by as novel key genes in biliary tract cancer (BTC)
Presenter: Massimiliano Salati
Session: ePoster Display
56P - Serum protein signatures as potential novel diagnostic biomarkers for biliary tract cancer
Presenter: Troels Christensen
Session: ePoster Display
57P - The characteristics of IDH mutations in Chinese bile duct carcinoma patients
Presenter: Yuwen Wang
Session: ePoster Display
58P - Intrahepatic cholangiocarcinoma (iCCA) hidden amongst the unknown: A retrospective analysis of cancer of unknown primary (CUP) cases from a tertiary cancer centre
Presenter: Alicia-Marie Conway
Session: ePoster Display
59TiP - Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Presenter: Jennifer Knox
Session: ePoster Display
62P - Markers in assessment of osteoporosis therapy efficiency in hormone-dependent breast cancer
Presenter: Nailya Guskova
Session: ePoster Display
63P - Obesity and sarcopenia as biomarkers for immunotherapy outcomes: A systematic review and meta-analysis
Presenter: Sophie Günther
Session: ePoster Display
155P - The addition of pyrotinib in early or locally advanced HER2-positive breast cancer patients with no response to two cycles of neoadjuvant therapy: A prospective, multicenter study
Presenter: zhi gang YU
Session: ePoster Display